Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colorectal OmiCs and Oncofetal Chondroitin Sulfate-modified Proteoglycans in Screening and Colorectal Cancer Diagnostic Pathway

NCT07237984 is registered in ClinicalTrials.gov with Nordsjaellands Hospital as lead sponsor.

NCT NCT07237984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07237984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colorectal OmiCs and Oncofetal Chondroitin Sulfate-modified Proteoglycans in Screening and Colorectal Cancer Diagnostic Pathway
Lead sponsor
Nordsjaellands Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 11, 2026
Completion date
December 31, 2031
Enrollment
2,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma, colorectal cancer, inflammatory bowel disease (ibd)